Fundraising FoxCorrectsequence
Shanghai, CN · 2 known investors
Find your way into Correctsequence
Sign up to see every warm intro you have to Correctsequence
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Correctsequence team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CorrectSequence Therapeutics develops base-editing gene therapies using its proprietary transformer Base Editor (tBE) platform to treat genetic diseases, rare diseases, and common conditions including inherited disorders, metabolic diseases, cardiovascular diseases, and cancers. The company has advanced multiple pipeline candidates into clinical and investigational stages, including programs for β-thalassemia and sickle cell disease.
Founders & leadership
陈
陈佳Founding Professor / Chief Scientific Advisor
牟
牟晓盾Chief Executive Officer
Investors · 2
Lilly Asia Ventureslisted by Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Correctsequence do?
- CorrectSequence Therapeutics develops base-editing gene therapies using its proprietary transformer Base Editor (tBE) platform to treat genetic diseases, rare diseases, and common conditions including inherited disorders, metabolic diseases, cardiovascular diseases, and cancers. The company has advanced multiple pipeline candidates into clinical and investigational stages, including programs for β-thalassemia and sickle cell disease.
- Who founded Correctsequence?
- Correctsequence was founded by 陈佳.
- Who are Correctsequence's investors?
- Correctsequence's investors include LAV, Lilly Asia Ventures.
- Where is Correctsequence headquartered?
- Correctsequence is headquartered in Shanghai, CN.